How much did Innervace raise?

Innervace raised $10 Million in a funding round on August 8, 2022.

Innervace reported raising $10 Million in an initial SEC Form D filing, from an offering of $40 Million

PRIVATEAug 22, 2022$10M of $40M raised

Amount Raised

$10 Million

$10 Million sold, per SEC Form D (first sale Aug 8, 2022)

Round Type

Venture

New YorkBiotechnology

Innervace raised $10 Million in a funding round, dated August 8, 2022. Innervace is based in New York, New York, United States.

How much did Innervace raise?: Innervace raised $10 Million in a funding round on August 8, 2022.
What does Innervace do?: Innervace is a regenerative therapy company developing technology that acts as pre-formed, anatomically-inspired, implantable tissue pathways to directly replace lost connections due to brain degeneration or injury.
Where is Innervace based and how big is it?: Innervace is based in New York, New York, United States.

Source: Fundz verified event record.

Companies in the same sectors as Innervace that raised within 45 days of this round, from Fundz verified event records.

Theralase® Technologies raised $2.5M (Seed) on September 22, 2022.
PATTERN HEALTH TECHNOLOGIES raised $3.3M (Series A) on September 22, 2022.
Roca Therapeutics raised an undisclosed amount (Seed) on September 22, 2022.
Whitehawk Therapeutics, Inc. raised $73M (Post-IPO Equity) on September 22, 2022.
Rivus Pharmaceuticals raised $132M (Series B) on September 22, 2022.
PERSOWN Diagnostics raised $344K (Seed) on September 22, 2022.

A new round usually means Innervace is about to hire and buy. The teams that reach out first get the meeting.

An alert the day Innervace raises, hires an executive or expands, scored against what you sell
The decision-makers there, with verified emails
Who you already know at Innervace, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Innervace. With Fundz connected, it knows.

Watch Fundz in

Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2